Vestibular schwannomas (VS)—benign tumors that grow on the nerve connecting the inner ear to the brain—affect about 1 in 100,000 people annually. For large, symptomatic cases (Koos grade 3–4, where the tumor touches or deforms the brainstem), surgery is often the best option to preserve nerve function and quality of life. But traditional surgical microscopes—while essential for precision—come with hidden costs: awkward surgeon postures, constant adjustments to refocus, and bulky equipment that crowds the operating field. Could a compact high-definition (HD) 2D exoscope solve these problems?
A 2020 study by Xin Chen and colleagues from Tianjin Medical University General Hospital explored this question, comparing a 2D exoscope to traditional microscopes for large VS resection. The results, published in the Chinese Medical Journal, offer promising insights for patients, surgeons, and the future of neurosurgery.
The Challenge with Traditional Microscopes
Traditional binocular microscopes are the gold standard for microsurgery because they provide 3D vision, magnification, and bright illumination. But they have key limitations:
- Shallow depth of field: Surgeons must stop and refocus constantly as they move instruments.
- Ergonomic strain: Surgeons hunch over eyepieces for hours, leading to neck, shoulder, and back pain.
- Bulky design: The microscope’s headstage and counterbalance system take up critical space, limiting instrument use.
- Training gaps: Assistants and trainees often see a different view than the surgeon, making learning harder.
The 2D exoscope addresses these issues with a simple design: a small rigid telescope mounted above the surgical field sends HD video to two 26-inch monitors (one for the lead surgeon, one for the assistant). Surgeons work from a neutral, upright position—no eyepieces required—and the system’s long focal length and deep depth of field reduce the need for adjustments.
What the Study Tested
The team enrolled 81 patients with large VS (Koos grade 3–4) between 2013 and 2018. Half were operated on with the exoscope (ViTOM, Karl Storz GmbH), and half with traditional microscopes (Leica M525 OH4 or Carl Zeiss OPMI PENTERO 900). Patients were matched for age, tumor size, and characteristics (cystic vs. solid) to ensure a fair comparison. All surgeries used the retrosigmoid approach (a common method accessing the tumor through the back of the skull) and were performed by the same experienced surgeon.
The study measured:
- Operative time
- Blood loss
- Number of field adjustments
- Tumor resection extent (gross-total, near-total, or sub-total)
- Facial (House-Brackmann scale) and cochlear nerve function (1 week and 3 months post-surgery)
- Surgeon comfort (0 = comfortable, 2 = severe pain)
Key Findings: Exoscope Wins on Comfort and Blood Loss
The results were clear—and encouraging:
- Less blood loss: Patients in the exoscope group lost an average of 190 mL vs. 230 mL with microscopes (P = 0.036). Less bleeding reduces complication risks like anemia or transfusion needs.
- Fewer adjustments: Surgeons needed just 3–4 field adjustments with the exoscope vs. 10 with microscopes (P < 0.001). No more stopping mid-surgery to refocus!
- Happier surgeons: 72% of lead surgeons and 95% of assistants reported “good” comfort (scores 0–1) with the exoscope—compared to 36% and 55% with microscopes (P = 0.001 and P < 0.001, respectively). No more hunching over eyepieces for hours.
Most importantly, the exoscope was just as safe and effective as the microscope:
- No difference in operative time (P = 0.172)
- No difference in tumor resection extent (P = 0.858)
- No difference in facial (P = 0.838) or hearing function (P = 1.000) 3 months post-surgery.
Why This Matters for Patients and Surgeons
For patients, the biggest win is less blood loss—a small but meaningful benefit that improves recovery. For surgeons, reduced fatigue means they can stay focused longer—critical for delicate brainstem surgery where even a split-second mistake matters. For training, the exoscope’s shared monitor lets trainees see exactly what the surgeon sees, making it easier to learn complex techniques.
As study author Shu-Yuan Yue notes, “After getting used to the 2D view—where motion parallax (moving instruments to judge depth) replaces stereopsis—surgeons get high-resolution visualization in a comfortable position. There’s no compromise on precision.”
Limitations and Future Directions
The study focused only on large VS (Koos grade 3–4), so we don’t know how the exoscope performs for smaller tumors or other neurosurgical procedures (e.g., gliomas, meningiomas). And while 2D worked well here, 3D exoscopes are emerging—future research will compare the two. But for large VS, this study suggests the 2D exoscope is a viable, patient- and surgeon-friendly alternative to traditional microscopes.
The Bottom Line
Neurosurgery is all about balance: removing disease while preserving function. This study shows that technology can help surgeons strike that balance better. The 2D exoscope isn’t just a “new tool”—it’s a solution to the hidden downsides of traditional microscopes, making complex surgery safer for patients and more sustainable for the surgeons who perform it.
As the authors conclude, “The compact HD 2D exoscope provides a safe, efficient means to remove large VSs—offering comfortable, high-resolution visualization without compromising outcomes.” For patients with large vestibular schwannomas, that’s a win. For surgeons, it’s a breath of fresh air (and a break from neck pain).
For more details, read the original study: Chen X, Gao XL, Chai Y, et al. Use of a compact high-definition two-dimensional exoscope in surgical treatment of large vestibular schwannoma. Chinese Medical Journal. 2020;133(11):1292–1297. doi.org/10.1097/CM9.0000000000000818
Was this helpful?
0 / 0